Panasonic Accuses CardioNexus Of Obscuring Software's Value

Law360, New York (July 16, 2012, 5:35 PM EDT) -- Panasonic Corp. on Sunday accused CardioNexus Corp. and two of its executives of misleading it into buying a minority stake in the medical device manufacturer by misrepresenting the value of and the status of regulatory approval for key software.

The tech giant says it invested $6.5 million in CardioNexus in October 2010 to help progress a new ultrasound diagnostic device called AIDA — which Panasonic had initially and independently developed — that is designed to allow for early detection and prevention of heart disease.

CardioNexus provided...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.